Arrowhead Publishers is pleased to announce its 4th Annual Translational Microbiome Conference is coming back to Boston in April 2018. The conference will once again bring together the top companies in the microbiome space working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.
The meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
Conference topics will include speakers and panels on:
♦ Skin Microbiome
♦ Microbiome Collectives
♦ Media and the Microbiome
♦ Intellectual Property Management
♦ Pharma Deals in the Microbiome Space
♦ Investment Deals in the Microbiome Space
The 2018 conference is being designed to offer attendees real insights and benefits that they can implement in their own organizations through the following features
First, the conference will feature a parallel track closely focused on the consumer industry and the specific challenges common to those companies trying to enter the microbiome space in this area.
In addition, the conference will offer multiple hands-on, intensive pre-conference workshops to help attendees understand real-world issues and give them tools to start understanding how those issues impact their businesses.